<DOC>
	<DOCNO>NCT03004469</DOCNO>
	<brief_summary>The purpose study confirm clinical efficacy safety P-3074 patient androgenetic alopecia .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety P-3074 Topical Solution Treatment Androgenetic Alopecia</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Written inform consent start study related procedure ; Men 18 40 year age ; Men mild moderate vertex male pattern hair loss accord modify Norwood/Hamilton classification scale ( III vertex , IV V ) ; Patients willing tattoo target area ; Outpatients ; Ability comprehend full nature purpose study , include possible risk side effect ; Ability cooperate Investigator comply requirement entire study . Clinically relevant abnormal skin scalp finding could interfere aim study ; particular , abrasion , actinic keratosis , inflammatory disorder abnormality ; Patients hair transplant surgery hair weave ; Clinically relevant abnormal laboratory value indicative physical illness ; Ascertained presumptive hypersensitivity active principle and/or formulation ' ingredient ; history anaphylaxis drug allergic reaction general , Investigator considers may affect outcome study ; History local infection skin subcutaneous tissue head 3months period trial inclusion ; Relevant history renal , hepatic , gastrointestinal , cardiovascular , respiratory , skin , haematological , endocrine neurological disease , may interfere aim study ; Suspicion malignancy , include prostate cancer ; History infertility difficulty father child ; Patients wish conceive child study whose sexual partner ( ) pregnant ; Patients active seborrheic dermatitis ; History varicocele ; Concurrent use systemic corticosteroid , topical corticosteroid bald area study , anabolic steroid , overthecounter `` hair restorer '' ; Use follow drug antiandrogenic property within 6 month study entry : flutamide , cyproterone acetate , estrogen , progesterone , cimetidine , spironolactone ketoconazole ; Patients treat follow drug within past year : minoxidil ( topical oral ) , zidovudine , cyclosporine , diazoxide , phenytoin , systemic interferon , psoralens , streptomycin , penicillamine , benoxaprofen , tamoxifen , phenothiazine cytotoxic agent ; Use finasteride dutasteride within previous 12 month ; Light laser treatment scalp within previous 3 month ; Participation evaluation drug 3 month study , calculate first day month follow last visit previous study ; History drug , alcohol [ &gt; 2 drinks/day define accord USDA Dietary Guidelines 2010 ] , caffeine ( &gt; 5 cup coffee/tea/day ) tobacco abuse ( 10 cigarettes/day ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>